Renaissance Technologies LLC acquired a new position in CME Group Inc (NASDAQ:CME) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 587,788 shares of the financial services provider’s stock, valued at approximately $96,350,000. Renaissance Technologies LLC owned 0.17% of CME Group at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Meeder Asset Management Inc. boosted its holdings in CME Group by 84.8% in the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock valued at $129,000 after purchasing an additional 362 shares during the period. Kaizen Advisory LLC raised its position in shares of CME Group by 151.9% during the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock valued at $134,000 after buying an additional 492 shares in the last quarter. Signaturefd LLC purchased a new stake in shares of CME Group during the 1st quarter valued at $138,000. Old Mutual Global Investors UK Ltd. purchased a new stake in shares of CME Group during the 1st quarter valued at $138,000. Finally, McKinley Carter Wealth Services Inc. purchased a new stake in shares of CME Group during the 1st quarter valued at $142,000. 84.03% of the stock is owned by institutional investors.

In related news, President Bryan T. Durkin sold 11,509 shares of CME Group stock in a transaction on Monday, August 6th. The shares were sold at an average price of $162.01, for a total value of $1,864,573.09. Following the transaction, the president now owns 64,862 shares in the company, valued at approximately $10,508,292.62. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jeffrey M. Bernacchi sold 4,976 shares of the business’s stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $176.60, for a total transaction of $878,761.60. Following the completion of the transaction, the director now owns 52,004 shares in the company, valued at approximately $9,183,906.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,888 shares of company stock worth $4,882,542. 0.57% of the stock is owned by corporate insiders.

Several analysts have recently weighed in on CME shares. Jefferies Financial Group restated a “buy” rating and set a $190.00 price objective on shares of CME Group in a research report on Wednesday. BidaskClub cut shares of CME Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 28th. Zacks Investment Research cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 5th. Wells Fargo & Co raised their price objective on shares of CME Group from $170.00 to $175.00 and gave the company a “market perform” rating in a research report on Monday, July 9th. Finally, Compass Point started coverage on shares of CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 price objective on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have given a buy rating to the company’s stock. CME Group presently has an average rating of “Buy” and a consensus target price of $174.40.

Shares of NASDAQ:CME opened at $173.78 on Friday. The firm has a market capitalization of $58.91 billion, a P/E ratio of 36.43, a price-to-earnings-growth ratio of 3.25 and a beta of 0.64. CME Group Inc has a 52 week low of $125.52 and a 52 week high of $177.35. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.02. The company had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The firm’s revenue was up 14.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.22 EPS. equities analysts forecast that CME Group Inc will post 6.68 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 25th. Investors of record on Monday, September 10th will be given a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 1.61%. The ex-dividend date is Friday, September 7th. CME Group’s payout ratio is presently 58.70%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: Book Value Per Share – BVPS

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.